197A Tauns Laboratories
- 607
- +6+1.00%
Tauns Laboratories News
Tauns Laboratories: Correction report (Large shareholding report / Change report)
Tauns Laboratories: Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K.
Tauns Laboratories: Notice of conclusion of a basic agreement on the basic transaction agreement between Towns and Roche Diagnostics
Tauns Laboratories: change report
Tauns Laboratories: Change report.
Tauns Laboratories: Notice regarding Preparation for Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
Tauns Laboratories: Notice regarding preparations for applying for a change in market classification to the Tokyo Stock Exchange Prime Market
Tauns Laboratories: Summary of financial results for the 1st quarter of the fiscal year ending 2025/6 [Japanese GAAP] (unconsolidated)
Tauns Laboratories: Supplementary Material on Financial Results for the Three Months Ended September 30, 2024
Tauns Laboratories: Financial Results for the Three Months Ended September 30, 2024 (Japanese Accounting Standards)
Tauns Laboratories: Presentation of financial results for the 1st quarter of the fiscal year ending 2025/6
Tauns Laboratories: Notice of participation in Triple I for Global Health (Impact Investment Initiative for Global Health)
Tauns Laboratories: Announcement of Participation in the Triple I for Global Health (Impact Investment Initiative for Global Health)
Tauns Laboratories: Announcement of Conclusion of License Agreement with First Screening Corp.
Tauns Laboratories: Notice of signing a license agreement with First Screening Co., Ltd.
Tauns Laboratories: Announcement of Acquisition of "Kurumin" Certification as a Child-Rearing Support Company
Tauns Laboratories: Notice of obtaining “Kurumin” certification as a child-rearing support company
Tauns Laboratories: Corporate Governance Report 2024/09/30
Tauns Laboratories: Extraordinary Report
Tauns Laboratories: Financial Report - Term 9 (2023/07/01 - 2024/06/30)
No Data